“I am happy to confirm our interest in the Plasma Medicine attributes of the Elanra MkII device. We have some significant findings in relation to a potential benefit of plasma medicine against COVID-19, as well as cancers in my field. We have identified a team of senior Researchers and Clinicians that can undertake rigorous testing on the latest Elanra MkII. These studies combined with sound scientific testing are important to formalise the extensive catalogue of community observations inside this company on human respiratory and immune health since 1967. The opportunity to apply such high level academic and medical standards was very likely not available when this device was invented.”